FDBusiness.com

Nestle to Acquire Pfizer Infant Nutrition Business

 Breaking News

Nestle to Acquire Pfizer Infant Nutrition Business

Nestle to Acquire Pfizer Infant Nutrition Business
April 18
11:54 2012
Spread the love

Pharmaceutical giant Pfizer is reported to be close to selling its $1.9 billion annual turnover infant nutrition business to Nestle for between $9 billion and $10 billion. With roughly 80% of its sales generated in high growth emerging markets and 60% in Asia, Pfizer’s infant nutrition business is an attractive acquisition target for the other major players within the infant formula industry. Asia accounts for about 45% of the world milk formula market and the region also accounts for over half of the births in the world.

Nestle is believed to have beaten rivals Danone and Mead Johnson to the prize.

 

About Author

mike

mike

Related Articles

Food & Drink Business Conference & Exhibition 2016

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements